Public and philanthropic investments in...

Public and philanthropic investments in AMR R&D related to fungi

28.01.2021: The Dynamic Dashboard now also shows data on projects financed by public and philanthropic funders that support human health-related AMR R&D addressing fungi. A short report with an initial analysis of the first set of more than 1000 such projects is available here.

Latest news

Go to all news

Brussels Discussions Advance Europe’s Antibiotic Innovation Agenda

The Global AMR R&D Hub contributed to two high-level discussions in Brussels on strengthening Europe’s antibiotic innovation ecosystem, with Deputy Director Dr. Ralf Sudbrak and Suzanne Edwards sharing evidence and expertise on investment, pull incentives, and the future of antibiotic R&D.

Fourth Working Session of Germany’s Parliamentary Group Against Antimicrobial Resistance

The Fourth Working Session of Germany’s Parliamentary Group against Antimicrobial Resistance explored how to strengthen the antibiotic innovation pipeline.

Global Health Security Conference 2026

The Global Health Security Conference 2026 highlighted a clear message: strong health systems must be built before a crisis strikes. The Global AMR R&D Hub joined discussions on why antimicrobial resistance is an essential component of global health security and how sustained investment in innovation can strengthen preparedness for future health threats.

Hub Vice Chair Prof. Liesl Zühlke Receives L’Oréal–UNESCO International Award for Women in Science

Hub Vice Chair Professor Liesl Zühlke has received the L’Oréal–UNESCO International Award for Women in Science in recognition of her outstanding contributions to global health.

Dynamic Dashboard